Literature DB >> 25835036

Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.

Tamara Castillo-Trivino1, Itziar Lopetegui2, Jose Antonio Alarcón-Duque3, Adolfo López de Munain4, Javier Olascoaga5.   

Abstract

Entities:  

Keywords:  MULTIPLE SCLEROSIS

Mesh：

Substances：

Year:  2015        PMID： 25835036     DOI： 10.1136/jnnp-2014-310013

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

Review 1.  [New aspects of immunotherapy in multiple sclerosis].

Authors:  K Pape; F Zipp; S Bittner
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

2.  Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.

Authors:  Volker Limmroth; Tjalf Ziemssen; Michael Lang; Stephan Richter; Bert Wagner; Judith Haas; Stephan Schmidt; Kathrin Gerbershagen; Christoph Lassek; Luisa Klotz; Olaf Hoffmann; Christian Albert; Katrin Schuh; Monika Baier-Ebert; Guillaume Wendt; Heinke Schieb; Susanne Hoyer; Ralf Dechend; Wilhelm Haverkamp
Journal:  BMC Neurol       Date:  2017-01-18       Impact factor: 2.474

Review 3.  Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies.

Authors:  Oliver Findling; Larissa Hauer; Thomas Pezawas; Paulus S Rommer; Walter Struhal; Johann Sellner
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.